Overall Technical outlook

Price Summary

On 2026-01-30, Mankind Pharma Limited's shares started at 2082.6, peaked at 2147.0, bottomed out at 2078.8, and ended 1.99% higher at 2124.0, with 535600 shares traded.
For the 52-week period, the stock's highest price is 2696.5, and the lowest price is 2094.2.
MANKIND's future price is expected to lie between 1990.0 and 3110.0, with an average expectation of 2632.0, as per the recommendations of 18 analysts.

Technicals

Support and Resistance: The price of 2124.0 is supported at 2111.2 and faces resistance at 2193.3. This range suggests key levels for MANKIND where the price may stabilize, with 2111.2 acting as a support and 2193.3 as a cap on gains.
MANKIND supportResistance 71c284
Support/Resistance for MANKIND


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
MANKIND aroon 71c284
Aroon chart for Mankind Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
MANKIND bbands 71c284
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR maintains its bearish stance, establishing a resistance level that could cap any attempts at upward movement. This persistent bearish outlook suggests that the market may continue to face downward pressure, with resistance preventing significant gains.
MANKIND psar 71c284
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
MANKIND stoch 71c284
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: A bullish trend is indicated by the alignment of the 20-50-100 period moving averages, though the slopes of the faster averages hint at a potential reversal. The weakening momentum in the shorter-term averages suggests that the current trend may not hold, signaling the possibility of an upcoming change in direction for MANKIND.
MANKIND trippleSMA 71c284
Tripple SMA chart for Mankind Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.